# Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus

> **NCT00672074** · PHASE2 · COMPLETED · sponsor: **Helsinn Therapeutics (U.S.), Inc** · enrollment: 117 (actual)

## Conditions studied

- Ileus

## Interventions

- **DRUG:** Ipamorelin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00672074
- **Lead sponsor:** Helsinn Therapeutics (U.S.), Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2017-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00672074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00672074, "Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00672074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*